NM_001036.6:c.5078C>T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001036.6(RYR3):c.5078C>T(p.Thr1693Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000892 in 1,613,898 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T1693T) has been classified as Likely benign.
Frequency
Consequence
NM_001036.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152068Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000128 AC: 32AN: 249302Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135252
GnomAD4 exome AF: 0.0000711 AC: 104AN: 1461712Hom.: 1 Cov.: 36 AF XY: 0.0000756 AC XY: 55AN XY: 727140
GnomAD4 genome AF: 0.000263 AC: 40AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74384
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.5078C>T (p.T1693M) alteration is located in exon 35 (coding exon 35) of the RYR3 gene. This alteration results from a C to T substitution at nucleotide position 5078, causing the threonine (T) at amino acid position 1693 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Epileptic encephalopathy Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at